Michael Whalen, MD, Urology, Washington, DC, George Washington University Hospital


Urology Washington, DC

Minimally Invasive Surgery, Surgical Oncology

Assistant Professor of Urology/Urologic Oncology, George Washington University Hospital/School of Medicine & Health Sciences

Dr. Whalen is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Whalen's full profile

Already have an account?

  • Office

    2150 Pennsylvania Ave Nw
    Dept Of Urology, GW MFA, Suite 3-417
    Washington, DC 20037
    Phone(202) 741-3100
    Fax(202) 741-3113
  • Is this information wrong?


  • Michael J. Whalen, MD is Assistant Professor of Urology with fellowship training and expertise in Urologic Oncology. Dr. Whalen’s specialty focus involves treatment of urological cancers, with expertise in both major open and minimally invasive surgery. His clinical interests include prostate cancer (including prostate MRI, MRI-ultrasound fusion biopsy and cryotherapy), bladder cancer (including blue-light cystoscopy and continent/incontinent urinary diversion), kidney cancer, testis cancer, adrenal cancer, ureteral cancer, robotic surgery with the DaVinci system (including prostatectomy, cystectomy, partial nephrectomy, and adrenalectomy) and laparoscopic surgery.
    Dr. Whalen is actively involved in clinical outcomes research focusing on cancer of the prostate, bladder, and kidneys. He has published numerous original research articles in peer-reviewed journals, including Urologic Oncology, Urology Practice, Prostate, Journal of Laparoendoscopic & Advanced Surgical Techniques, and BJU International. His research interests include robotic surgery techniques, optimization of pathologic reporting of urological cancers, and multiparametric magnetic resonance imaging (mp-MRI) and its role in prostate cancer management—active surveillance, post-treatment biochemical recurrence, focal ablation, and comparison to/integration with commercially-available serum-based and tissue-based genomic assays.
    Dr. Whalen has presented at numerous conferences in the US and internationally, including the American Urological Association (AUA) National Conference, the AUA New York Section Ferdinand C. Valentine Medal & Resident Essay Meeting, the 2016 World Cancer Congress in Shanghai, China, and the 2014 AUA National Chief’s Debate, which he won as a representative of the New York Section. He is a member of the American Urological Association. He has reviewed articles for Current Urology and served as a reviewer/statistical consultant for the Journal of Urology.

Education & Training

  • New York Presbyterian Hospital -  Columbia Campus
    New York Presbyterian Hospital - Columbia CampusResidency, Urology, 2009 - 2014
  • New York Presbyterian Hospital
    New York Presbyterian HospitalInternship, Transitional Year, 2008 - 2009
  • Columbia University College of Physicians & Surgeons
    Columbia University College of Physicians & SurgeonsClass of 2008

Certifications & Licensure

  • VA State Medical License
    VA State Medical License 2020 - 2022
  • MD State Medical License
    MD State Medical License 2018 - 2021
  • DC State Medical License
    DC State Medical License 2016 - 2022
  • CT State Medical License
    CT State Medical License 2015 - 2017
  • NY State Medical License
    NY State Medical License 2009 - Present
  • American Board of Urology Urology

Awards, Honors, & Recognition

  • National Chief Resident Debate Winner American Urological Association, 2014
  • Chief Resident Debate runner up New York Section of the American Urological Association, 2014
  • Valentine Essay Contest Manuscript Presentation New York Section of the American Urological Association, 2013-2014

Publications & Presentations


Authored Content

  • Lymph Node Yield During Radical Prostatectomy Does Not Impact Rate of Biochemical Recurrence in Patients with Seminal Vesicle Invasion and Node-Negative DiseaseApril 2018

Press Mentions

  • Close Surgical Margins Raise Risk of Prostate Cancer Return
    Close Surgical Margins Raise Risk of Prostate Cancer ReturnFebruary 12, 2016 18:32

Professional Memberships

Other Languages

  • Spanish, French

Hospital Affiliations